Income Statement

GUARDIAN PHARMACY SERVICES, INC.

GRDN

Performance Overview Click any row in the table to add it to this chart

in millions USD

Metric	Dec 31, 2025 2025 FY	Dec 31, 2024 2024 FY
Revenue	1,448.69	1,228.41
Cost of Revenue	1,155.97	984.04
Gross Profit	292.72	244.37
Operating Expenses	220.02	307.29
Research & Development	-	-
Selling, General & Administrative	220.02	307.29
Other Operating Expenses	-	-
Operating Income	72.70	-62.92
Non-Operating Income	0.72	-3.56
Interest Income	-	-
Interest Expense	0.67	3.28
Other Non-Op Income / Expense	1.39	-0.28
Income Before Tax	73.42	-66.48
Income Tax Expense	24.20	43.57
Non-Controlling Interest	-0.26	16.25
Net Income	49.22	-110.05

Supplemental Per share data, derived & other items — not part of the income statement

in millions USD unless noted